Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DORA: Delstrigo Switch Study in Women with HIV-1
NCT04433780Phase 3Completed
- Start
- Jan 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doravirine in human immunodeficiency virus type 1 infection (HIV-1). Started Jan 2021; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04433780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433780.